This review will analyze growing evidence suggesting a convergence between two major areas of research: Alzheimer's disease (AD) and chaperonopathies. While AD is a widely recognized medical, public health, and social problem, the chaperonopathies have not yet been acknowledged as a related burden
Chaperonoterapy for Alzheimer's Diseases: Focusing on HSP60
2015
Abstract
This review will analyze growing evidence suggesting a convergence between two major areas of research: Alzheimer's disease (AD) and chaperonopathies. While AD is a widely recognized medical, public health, and social problem, the chaperonopathies have not yet been acknowledged as a related burdenFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
